PTCH1 and neoplasm: In NBCCS patients presenting systemic loss of one functional copy (haploinsufficiency) of PTCH1, inactivation of the normal homolog by environmental mutagenesis or random genetic rearrangement confers ligand-independent activation of the Hh pathway and tumour permissive phenotype [29].